Establishment and molecular characterization of a human ovarian clear cell carcinoma cell line (FDOV1)

Genomic landscape of ovarian clear cell carcinoma via whole exome sequencing

(2018) Se Ik Kim et al.   GYNECOLOGIC ONCOLOGY

Geographical variations in incidence, management and survival of hepatocellular carcinoma in a Western country

(2017) Nathalie Goutté et al.   JOURNAL OF HEPATOLOGY

The critical role of the ZNF217 oncogene in promoting breast cancer metastasis to the bone

(2017) Aurélie Bellanger et al.   JOURNAL OF PATHOLOGY

The genetic landscape of endometrial clear cell carcinomas

(2017) Deborah F DeLair et al.   JOURNAL OF PATHOLOGY

Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study

(2016) Yinzhi Lai et al.   GASTROENTEROLOGY

Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial

(2016) Toru Sugiyama et al.   JOURNAL OF CLINICAL ONCOLOGY

Establishment and characterization of a clear cell carcinoma cell line, designated NOCC, derived from human ovary

(2016) Akihiro Ohyama et al.   Human Cell

Establishment and characterization of a novel ovarian clear cell carcinoma cell line, TU-OC-2, with loss of ARID1A expression

(2016) Seiya Sato et al.   Human Cell

Establishment and characterization of a cell line (HCH-1) originating from a human clear cell carcinoma of the ovary

(2016) Takashi Yamada et al.   Journal of Ovarian Research

The Molecular Taxonomy of Primary Prostate Cancer

(2015) Adam Abeshouse et al.   CELL

Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence

(2015) Tanya Keenan et al.   JOURNAL OF CLINICAL ONCOLOGY

Coexistent ARID1A–PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling

(2015) Ronald L. Chandler et al.   Nature Communications

Comprehensive analysis of targetable oncogenic mutations in chinese cervical cancers

(2015) Libing Xiang et al.   Oncotarget

SPOP mutation leads to genomic instability in prostate cancer

(2015) Gunther Boysen et al.   eLife

Global distribution pattern of histological subtypes of epithelial ovarian cancer: A database analysis and systematic review

(2014) Pi-Lin Sung et al.   GYNECOLOGIC ONCOLOGY

Chromosome 20q13.2 ZNF217 locus amplification correlates with decreased E-cadherin expression in ovarian clear cell carcinoma with PI3K-Akt pathway alterations

(2014) Hsien-Neng Huang et al.   HUMAN PATHOLOGY

Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Ovary

(2014) Aikou Okamoto et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes

(2014) Siân Jones et al.   Nature Communications

Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations and ZNF217 amplification in ovarian clear cell carcinoma

(2013) Hsien-Neng Huang et al.   MODERN PATHOLOGY

Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene

(2013) Hiroaki Itamochi et al.   Human Cell

Mutational and expressional analyses ofSPOP, a candidate tumor suppressor gene, in prostate, gastric and colorectal cancers

(2012) Min S. Kim et al.   APMIS

Clear cell carcinoma of the ovary: A review of the literature

(2012) Marcela G. del Carmen et al.   GYNECOLOGIC ONCOLOGY

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

(2012) Christopher E Barbieri et al.   NATURE GENETICS

The Transcription Factor ZNF217 Is a Prognostic Biomarker and Therapeutic Target during Breast Cancer Progression

(2012) Laurie E. Littlepage et al.   Cancer Discovery

Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma

(2011) Mohammed Tanjimur Rahman et al.   CANCER

Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010

(2011) Michael S. Anglesio et al.   GYNECOLOGIC ONCOLOGY

Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations

(2011) Sohei Yamamoto et al.   MODERN PATHOLOGY

Establishment and Characterization of the RMG-V Cell Line from Human Ovarian Clear Cell Adenocarcinoma

(2010) Daisuke AOKI et al.   Human Cell

Diverse somatic mutation patterns and pathway alterations in human cancers

(2010) Zhengyan Kan et al.   NATURE

ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas

(2010) Kimberly C. Wiegand et al.   NEW ENGLAND JOURNAL OF MEDICINE

Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma

(2010) Siân Jones et al.   SCIENCE

Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma

(2009) Kuan-Ting Kuo et al.   AMERICAN JOURNAL OF PATHOLOGY